EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS012-16435 
Organism
Homo sapiens 
Tissue/cell
Caco-2 
Coordinate
chr2:114552240-114554930 
TF binding sites/motifs
Number: 25             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr2:114552324-114552342GGAAGGAAGGAAGGAAAG+10.53
EWSR1-FLI1MA0149.1chr2:114552290-114552308GGAAGGAAAGAAAGAGAG+6.04
EWSR1-FLI1MA0149.1chr2:114552274-114552292AGAAAGAAAGAAGGAAGG+6.56
EWSR1-FLI1MA0149.1chr2:114552312-114552330AGAAAGAAAGAAGGAAGG+6.56
EWSR1-FLI1MA0149.1chr2:114552332-114552350GGAAGGAAAGAAAGAAAG+6.95
EWSR1-FLI1MA0149.1chr2:114552278-114552296AGAAAGAAGGAAGGAAGG+7.85
EWSR1-FLI1MA0149.1chr2:114552316-114552334AGAAAGAAGGAAGGAAGG+7.85
EWSR1-FLI1MA0149.1chr2:114552282-114552300AGAAGGAAGGAAGGAAAG+8.46
EWSR1-FLI1MA0149.1chr2:114552286-114552304GGAAGGAAGGAAAGAAAG+8.46
EWSR1-FLI1MA0149.1chr2:114552328-114552346GGAAGGAAGGAAAGAAAG+8.46
EWSR1-FLI1MA0149.1chr2:114552320-114552338AGAAGGAAGGAAGGAAGG+9.09
IRF1MA0050.2chr2:114552340-114552361AGAAAGAAAGAGAAAGAGAGA-6.56
IRF1MA0050.2chr2:114552366-114552387AGAAAGAAAGAGAAAGAAAGA-6.76
IRF1MA0050.2chr2:114552242-114552263GAAAAGAAAGAGAAAGAAAGA-7.17
Klf1MA0493.1chr2:114553540-114553551TGGGTGTGGCC-6.62
NFICMA0161.2chr2:114554210-114554221TACTTGGCAGA+6.62
Nkx3-2MA0122.3chr2:114554706-114554719GTTAAGTGTTTTT-6.06
ZNF143MA0088.2chr2:114553065-114553081TACCCACCATGCATCA+7.12
ZNF263MA0528.1chr2:114552329-114552350GAAGGAAGGAAAGAAAGAAAG+6.02
ZNF263MA0528.1chr2:114552283-114552304GAAGGAAGGAAGGAAAGAAAG+6.03
ZNF263MA0528.1chr2:114552325-114552346GAAGGAAGGAAGGAAAGAAAG+6.03
ZNF263MA0528.1chr2:114552287-114552308GAAGGAAGGAAAGAAAGAGAG+6.27
ZNF263MA0528.1chr2:114552891-114552912GGAGGATGAGAGGAATGAAAG+6.41
ZNF263MA0528.1chr2:114552321-114552342GAAGGAAGGAAGGAAGGAAAG+6.48
ZNF263MA0528.1chr2:114552389-114552410GAAAGAGGGAGGGAGGGGAAA+6
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr2114554192114554804
chr2114553241114553377
Number: 1             
IDChromosomeStartEnd
GH02I113796chr2114554425114554878
Enhancer Sequence
AAGAAAAGAA AGAGAAAGAA AGAAAGAGAG AGAAAGAAAG AAAGAAGGAA GGAAGGAAAG 60
AAAGAGAGAG AGAGAAAGAA AGAAGGAAGG AAGGAAGGAA AGAAAGAAAG AGAAAGAGAG 120
AAAGAAAGAA AGAAAGAGAA AGAAAGAAAG AAAGAGGGAG GGAGGGGAAA ACAGTTGAAA 180
TGGAGGTCGA GGAGAGGAAG ACATGTACAG AGAGAAAAGC TACATTGCAA TTACGGTGAG 240
GTCATGAGAA TAAGAGTAGT ATGTCTGCTT CTGAGGTGGC CACAAGCTTA CTGGGCAACA 300
CAATTACTGT GCAACCCTCA ATGATGTTCG ATTTTACATG CAGTCAGTAT GCAGAGCTGC 360
AGAGAGGTTT CCTCGCCAAT TTTGTAAACT TATAAGAAAT GCCTCCTATC TGACATGTCT 420
GTGCCGTAGA ATATAGTGGA TGCTGTTGTG AGATGTAAGA TTACAGTGGA TGCTGTTGTG 480
GGATGTAAGA TTCATCTCTC CCCTCACCTG GTACCATCTT TTCAGAAATA CATCACTCAT 540
TTTCCTAGCT GCTGGGAGTA TTGAAGGCTG ACAGCTCTCA GCTGAATCAC CAAAGCTGCC 600
TCACTCAAGG TCACTGCCCT GGAGGCAGCC CTTATCTAAA CATGGGAGGT GGGAGGATGA 660
GAGGAATGAA AGCCCAGCAT GCTTGCCTCT GCTGGGGACA ACTTTATAGG TCCACAGTGC 720
CTCCAGGGAT CAGTTGAGTC CTTTATTGTC ACTACACAGC AATTCATCAT TTCCCTCTGC 780
TTATTCCTGT GTCCTTCACT CCCCCTCATA TACTGATGCC CAAAATACCC ACCATGCATC 840
AGCCCCTATA GACTCCCTAC ATGCAAATCT CAGATTCCCA ATGTCTGATT TTCAGGGAAC 900
ACAGCCTGCA GCCCAGATTA ACACACACTG GTCCTTACGC CAAATAAGAC AAGCAGTCCA 960
GCTGTTTCTG TCACCCTCCC ACCAATATCT CTGAGAGCTC CTGCCAGGCT TGAATTAACA 1020
ACCATCACGC TCCTCTTCCC AAACACAACT CAGTCATCAG CACTGGAAAG TACAGCCAGC 1080
TCAGCCTCAA TAAGGTTCAA CTCTAGAGCC ACGGAAGGTA TTTCCTGGAT CATGCAATGA 1140
TGCAGAAAAG CAGCCACTGC CTTCTCAGCT GCCTTTTCCA GGGTCCATTT GAGGCTCCAT 1200
TACCACTGGC TAGTTAGAGA TTGTGAATGT ACAGCTGCAC AGGGCACAGC AATTAATGTT 1260
TCGGGTGTGG ATGCCACAGA CCTGAAATGC TCTTCTGACA TGGGTGTGGC CACCAAATAA 1320
GAAATCTTGG TGGGAATGGC TTTACTTGAG CCAGAGGTCT GCATTTTGTT TCTGGTTGTC 1380
ATCTTTAGGG AGATGTCTGC AGCACTTGCA GCTGGAAGCC CAAACTGGAG AGACTCTGCT 1440
GCCACAAATA AGAATGGCAG ACTGGCCATC TGACTGTGAC CATGCAGATG AGCAGGAGGG 1500
AGATTCTTGT GGGATTCCAG CTAAATTCAA AATTTCAGTG CCAATGTGAT GTGTTTAAAG 1560
GTAAGCCAGG AACTTTATCT CAGCCCCAAG CAGCAGACAT TAACAGTGAT GGTGTTAAGG 1620
AAAAGACATT GGCTATGTGT TATGAATGAG TATCAGTGCA CAAAACGAGT TATTAAAAAA 1680
AACTACACGT CTTTACGAGT GCAATGGCGC GATCTCGGCT CACCACAACC TCCACCTTCC 1740
GGGTTCAAGC AATTCTCCTG TCGCAGCCTC CCAAGTAGCT GGGATTACAG GCATGCACCA 1800
CCATGCCTGG CTAATTTTGT ATTTTTAGTA GAGACGGGGT TTCTCCATGT TGGTCAGGCT 1860
GGTCTCGAAC TCCTGAACTC ATGATCCTCC CACCTCGGCC TCCCAAAGTG CTGGGATTAC 1920
AGGTGTGAGC CACTGTGCCT GGCCAATATT TTCAAGACTG TTTTATGATC TACTTGGCAG 1980
ACTACTTAAC TTGCACTTAA CATGAAAGGA GAAAAAACAT AAAGCCATTC ATACTTCTGC 2040
AAGTTGACCT TAAATATATC GTCAAGCCAT AAATTGACTT CTAGAAGAGG ACAAAGGGAA 2100
ACACGCCTAT AAAAATCTTA GGACAGCCTG TATGATTGTC CAATTGTGAA GATTAAAGCA 2160
ACTCCATCTT GGACGCTAAT CTGCTATGTT GACTTCTGAT TGACCCCTGT TCCAGGAATG 2220
CCTCTAAGAT TTCTCCTTTA TCTACTGTTA CTATAAATCC TGCCCTTTGT TCAAAACGAC 2280
CTTTACCATA CATCCTGCGT TTAGGTAGAT TCACATTGCC TTGTTGCCTT TCCCTGAGGG 2340
GTCAGCTTTA ACTGTCCTAC ACATTCCTTC CCTATGGTAT ATACCCTGAG TCTGGGTGGA 2400
AATGGCCTGG GAATCCGCCA TCTCTTCTGT GGCTGCCTAG GACATAGCTT CTGTTCATAA 2460
CTCCCTGTTA AGTGTTTTTT TCTGAGGGAG TGGATTTGTC AGCCTCATTC TTCAGACTCT 2520
CAGCTTCCTT GGCCTTTGGG GTTAGGTTTG CATAGACTTG CTCACTGTGG AACATCAATA 2580
AACCTACAAA TTCACCTGCC TGAGTCGTAT TGTAGGAATT ACAGCAGATA AATGAACAGA 2640
ACATTGTCAA ATGAAATAAT GCTCTGTGCA TGATTAATTA TTTTAACTAG 2690